Want to join the conversation?
$GILD said combination of sofosbuvir and velpatasvir (SOF/VEL) for 12 weeks was authorized for use in patients without cirrhosis or with compensated cirrhosis and in combination with ribavirin (RBV) for patients with decompensated cirrhosis. SOF/VEL is also first single tablet regimen approved to treat HCV genotype 2 and 3, without need for RBV.
Chipotle stock is crashing like a falling knife after it's earnings report last evening; down about 10% already today! Was Bill Ackman wrong in buying about 10% stake in $CMG couple of months ago? Or is this market reacting to disappointing earnings? And can they really get customers to trust them again after food-safety crisis?
$TSLA Just recalling Elon Musk's statement during Q4 earnings. "I am presently quite excited about is that we expect to be positive cash flow starting next month, and then continuing on into Q2 and beyond." Will the electric carmaker prove that it can be cash flow positive company this quarter?
While all of us are busy with crunching earnings numbers that are flowing in this week, keep an eye on WTI Crude prices also for broader economic trends. Russians have rejected any production cuts after OPEC nations recently decided to cut oil production. OPEC had finally decided to cut prod to spur up prices! What sectorscan be most affected if prices do go up in the next 6 months? Airlines for sure! Image courtesy: Bloomberg
Apple ($AAPL) reported decline in sales and profits from comparable quarter last year, attributing the decline to announcement of iPhone 7/7s. Sales and profit are being guided higher for next quarter. Apple is a solid company and will continue to dominate tech and consumer electronics segment for a while. Personally, looks like there is little downside in this investment.
Waiting with fingers crossed for $AAPL’s fourth quarter earnings.